Brankovic Milos, Sharma Abhishek
Division of Cardiology, Department of Medicine, New Jersey Medical School, 185 South Orange Avenue, Newark, NJ, USA.
Transatlantic Cardiovascular Study Group, West Orange, Newark, NJ, USA.
Curr Cardiol Rep. 2022 Dec;24(12):1901-1906. doi: 10.1007/s11886-022-01808-z. Epub 2022 Oct 25.
Transcatheter valve therapies for mitral and tricuspid regurgitation are alternative methods to more invasive surgical treatment in candidates with high or prohibitive surgical risk. Echocardiography is the primary imaging modality for patient selection, pre-procedural planning, intra-procedural guidance, and post-procedural follow-up.
This article outlines the applications of transcatheter valve repair therapy for mitral and tricuspid regurgitation based on the current cardiovascular guidelines and a growing body of evidence. In this review, we provide a stepwise approach echocardiography in the guidance of the MitraClip device as currently the only FDA-approved transcatheter edge-to-edge repair device.
对于手术风险高或手术禁忌的二尖瓣和三尖瓣反流患者,经导管瓣膜治疗是比侵入性更强的外科治疗更具替代性的方法。超声心动图是用于患者选择、术前规划、术中引导和术后随访的主要成像方式。
本文根据当前心血管指南和越来越多的证据,概述了经导管瓣膜修复治疗二尖瓣和三尖瓣反流的应用。在本综述中,我们提供了一种在MitraClip装置引导下进行超声心动图检查的逐步方法,该装置是目前唯一获得美国食品药品监督管理局批准的经导管缘对缘修复装置。